Compared with the BC group, il-8 expression in the L group was significantly (p < 0.05) reduced, indicating that the expression of proinflammatory factors could be inhibited after treatment with the probiotic complex, thereby inhibiting the inflammatory response. The gene discussed is CXCL8; the disease is breast cancer.